NCT00048412View on ClinicalTrials.gov

Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2000

Primary Completion Date

November 12, 2004

Study Completion Date

November 12, 2004

Conditions
Myelodysplastic DisordersLeukemiaMultiple MyelomaPlasma Cell DyscrasiaLymphoproliferative Disorders
Interventions
DRUG

FLUDARABINE

DRUG

CAMPATH 1H

DRUG

FK50

PROCEDURE

Stem Cell Collection and Infusion

Trial Locations (2)

77030

Texas Children's Hospital, Houston

The Methodist Hospital, Houston

All Listed Sponsors
collaborator

The Methodist Hospital Research Institute

OTHER

collaborator

Center for Cell and Gene Therapy, Baylor College of Medicine

OTHER

lead

Baylor College of Medicine

OTHER

NCT00048412 - Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H | Biotech Hunter | Biotech Hunter